ACER THERAPEUTICS INC.: cashflow_financing
| Value | {"amount": 7139047, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | ACER THERAPEUTICS INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:35:24.233006+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/dccde2e7-e56a-479e-b817-84edad10cb31
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-22-008350 · Open the official SEC filing →Retrieved: 2026-08-19T10:35:24.233006+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001069308/cashflow-financing/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/dccde2e7-e56a-479e-b817-84edad10cb31
History
- no predecessors — first report